Skip to content
InfuSystem Holdings logo

InfuSystem Holdings

INFU

InfuSystem Holdings, Inc. is a leading national healthcare service provider specializing in outpatient care and last-mile solutions for Durable Medical Equipment (DME).

Market cap
$188.9M+57.7%
Revenue$142.4M+3.5%
Net income$7.9M+148%
Free cash flow$23.0M+10.5%
EPS (diluted)$0.37+164%
Trailing twelve months · change vs. prior year

Earnings

Next report

Aug 4, 2026 (In 6 days)
Revenue estimate$36.4M
EPS estimate$0.12

Financials

Q1 2026

Income statement

See full
Revenue$33.7M-3.0%
Gross profit$19.7M+2.7%
Operating income$1.6M+157%
Net income$1.0M+481%
EPS (diluted)$0.05+600%

Balance sheet

See full
Cash & equivalents$2.1M+39.8%
Total debt$24.1M-30.4%
Total equity$58.7M+6.5%
Total assets$98.7M-5.4%

Cash flow

See full
Operating cash flow$970.0K-45.5%
CapEx$157.0K+19.8%
Free cash flow$813.0K-50.7%

Valuation & ratios

Valuation

See full
Market cap$188.9M+57.7%
Enterprise value$210.9M+36.1%
P/E23.9×-0.5×
P/S1.3×+0.4×

Profitability

See full
Gross margin56.7%+3.6pp
Operating margin9.1%+3.0pp
Net margin5.6%+3.2pp
FCF margin16.2%+1.0pp

Returns & leverage

See full
Return on equity13.9%+8.0pp
Debt / equity0.4×-0.2×
Current ratio2.1×-0.1×

Segments

By segment

See full
Patient Services$22.1M+6.4%
Device Solutions$13.2M-16.4%

By product

See full
Services$2.8M+18.8%
Direct rental services$2.0M+2.6%

Competitors

Profile

InfuSystem Holdings, Inc. is a leading national healthcare service provider specializing in outpatient care and last-mile solutions for Durable Medical Equipment (DME). The company facilitates clinic-to-home healthcare by providing infusion pumps, related supplies, and comprehensive support services that allow patients to receive complex treatments like chemotherapy in their own homes. Its core value proposition centers on reducing healthcare costs and improving patient outcomes through a specialized service model that integrates logistics, billing, and 24/7 clinical support.

Competitive position

A leading national provider with a massive network of nearly 840 third-party payer contracts and a large fleet of approximately 96 different makes and models of equipment.

GeographiesUnited States, Canada
Customer segmentsHospitals, Specialty Clinics, Outpatient Centers, Third-party Payers
Business modelEquipment Rental, Direct Sales, Service-as-a-Product, Revenue Cycle Management
SuppliersDurable Medical Equipment manufacturers, Pharmaceutical companies, Information technology infrastructure providers, Cleaning and sterilization agent suppliers
CustomersOncology patients, Private oncology clinics, Hospital outpatient departments, Ambulatory surgery centers, Third-party insurance payers
Listed1992
Employees516.0
CEOCarrie A. Lachance
FilingsSEC EDGAR

Questions, answered.

What is InfuSystem Holdings's market cap?
InfuSystem Holdings (INFU) has a market capitalization of $188.9M and trades on AMEX.
What is InfuSystem Holdings's revenue and profitability?
InfuSystem Holdings generated $142.4M in trailing twelve-month revenue with net income of $7.9M, representing a net margin of 5.6%. Gross margin stands at 56.7%, with free cash flow of $23.0M. These figures are based on the Q1 2026 filing.
Who are InfuSystem Holdings's competitors?
InfuSystem Holdings's key competitors include Option Care Health, Inc., Baxter International Inc., Becton, Dickinson and Company, and others. These companies compete in similar markets and product categories.
Who does InfuSystem Holdings partner with?
InfuSystem Holdings's notable partners include Sanara MedTech Inc., ICU Medical, Inc., Smith & Nephew, and others.
What subsidiaries does InfuSystem Holdings have?
InfuSystem Holdings's subsidiaries include InfuSystem, Inc., Apollo Medical Supply, FilAMed, and others.
Where is InfuSystem Holdings headquartered?
InfuSystem Holdings is headquartered in United States of America and employs approximately 516 people. It has been publicly traded since 1992.